Ibrutinib for Chronic Lymphocytic Leukemia

被引：0
|
作者：
Sharman, Jeff P. [1 ]
Mato, Anthony R. [2 ]
Keating, Michael J. [3 ]
机构：
[1] Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 16期
关键词：
PREVIOUSLY UNTREATED PATIENTS; CHLORAMBUCIL; THERAPY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1592 / 1593
页数：2
相关论文
共 50 条
  • [41] Ibrutinib and its use in the treatment o chronic lymphocytic leukemia
    Frustaci, Anna Maria
    Tedeschi, Alessandra
    Deodato, Marina
    Mazzucchelli, Maddalena
    Cairoli, Roberto
    Montillo, Marco
    FUTURE ONCOLOGY, 2018, 14 (08) : 681 - 697
  • [42] Ibrutinib reprograms the glucocorticoid receptor in chronic lymphocytic leukemia cells
    Shi, Yonghong
    Wang, Guizhi
    Muhowski, Elizabeth M.
    Mccaw, Lindsay
    Wang, Catherine
    Bjarnason, Georg
    Woyach, Jennifer A.
    Spaner, David E.
    LEUKEMIA, 2019, 33 (07) : 1650 - 1662
  • [43] Chronic lymphocytic Leukemia Ibrutinib was superior to Chlorambucil as Initial Therapy
    Homrich, Mirka
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (05) : 309 - 309
  • [44] Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia
    Kidoguchi, Keisuke
    Kubota, Yasushi
    Nishimura, Yuki
    Kizuka-Sano, Haruna
    Kimura, Shinya
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (01) : 83 - 85
  • [45] Ibrutinib reprograms the glucocorticoid receptor in chronic lymphocytic leukemia cells
    Yonghong Shi
    Guizhi Wang
    Elizabeth M. Muhowski
    Lindsay McCaw
    Catherine Wang
    Georg Bjarnason
    Jennifer A. Woyach
    David E. Spaner
    Leukemia, 2019, 33 : 1650 - 1662
  • [46] Invasive Aspergillosis Related To Ibrutinib Therapy For Chronic Lymphocytic Leukemia
    Arthurs, B.
    Hsu, M.
    Dobos, N.
    Grochowski, C.
    Kim, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [47] Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia
    Wang, Song-Yau
    Ebert, Thomas
    Jaekel, Nadja
    Schubert, Stefan
    Niederwieser, Dietger
    Al-Ali, Haifa Kathrin
    ANNALS OF HEMATOLOGY, 2015, 94 (08) : 1419 - 1420
  • [48] Efficacy and Safety of Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia
    Cao, Zhijian
    Ma, Jun
    BLOOD, 2019, 134
  • [49] IBRUTINIB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA
    McDermott, J.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (04) : 291 - 300
  • [50] STRATEGIES TO FIGHT IBRUTINIB-RESISTANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Frezzato, F.
    Visentin, A.
    Davanzo, V.
    Severin, F.
    Pizzo, S.
    Ruggeri, E.
    Tonini, A.
    Facco, M.
    Piazza, F.
    Semenzato, G.
    Trentin, L.
    HAEMATOLOGICA, 2020, 105 : S97 - S98
12345